Ansari M - Search Results

1

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

Uppugunduri CRS, Storelli F, Mlakar V, Huezo-Diaz Curtis P, Rezgui A, Théorêt Y, Marino D, Doffey-Lazeyras F, Chalandon Y, Bader P, Daali Y, Bittencourt H, Krajinovic M, Ansari M. Uppugunduri CRS, et al. Among authors: ansari m. Front Pharmacol. 2017 Jul 11;8:451. doi: 10.3389/fphar.2017.00451. eCollection 2017. Front Pharmacol. 2017. PMID: 28744217 Free PMC article.

2

Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.

Ansari M, Krajinovic M. Ansari M, et al. Curr Opin Pediatr. 2007 Feb;19(1):15-22. doi: 10.1097/MOP.0b013e3280140613. Curr Opin Pediatr. 2007. PMID: 17224657 Review.

3

[Pharmacogenomics of acute lymphoblastic leukemia].

Ansari M, St-Onge G, Krajinovic M. Ansari M, et al. Med Sci (Paris). 2007 Nov;23(11):961-7. doi: 10.1051/medsci/20072311961. Med Sci (Paris). 2007. PMID: 18021708 Free article. French.

4

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.

Dulucq S, St-Onge G, Gagné V, Ansari M, Sinnett D, Labuda D, Moghrabi A, Krajinovic M. Dulucq S, et al. Among authors: ansari m. Blood. 2008 Apr 1;111(7):3692-700. doi: 10.1182/blood-2007-09-110593. Epub 2007 Dec 20. Blood. 2008. PMID: 18096764 Free article.

5

Pharmacogenomics of acute leukemia.

Ansari M, Krajinovic M. Ansari M, et al. Pharmacogenomics. 2007 Jul;8(7):817-34. doi: 10.2217/14622416.8.7.817. Pharmacogenomics. 2007. PMID: 18240908 Review.

6

IV busulfan dose individualization in children undergoing hematopoietic stem cell transplant: limited sampling strategies.

Dupuis LL, Sibbald C, Schechter T, Ansari M, Gassas A, Théorêt Y, Kassir N, Champagne MA, Doyle J. Dupuis LL, et al. Among authors: ansari m. Biol Blood Marrow Transplant. 2008 May;14(5):576-82. doi: 10.1016/j.bbmt.2008.03.002. Biol Blood Marrow Transplant. 2008. PMID: 18410900 Free article.

7

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.

Ansari M, Sauty G, Labuda M, Gagné V, Laverdière C, Moghrabi A, Sinnett D, Krajinovic M. Ansari M, et al. Blood. 2009 Aug 13;114(7):1383-6. doi: 10.1182/blood-2008-11-191098. Epub 2009 Jun 10. Blood. 2009. PMID: 19515727 Free article.

8

DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia.

Al-Shakfa F, Dulucq S, Brukner I, Milacic I, Ansari M, Beaulieu P, Moghrabi A, Laverdière C, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Sinnett D, Krajinovic M. Al-Shakfa F, et al. Among authors: ansari m. Clin Cancer Res. 2009 Nov 15;15(22):6931-8. doi: 10.1158/1078-0432.CCR-09-0641. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861437

9

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

Ansari M, Krajinovic M. Ansari M, et al. Pharmacogenomics. 2009 Nov;10(11):1729-32. doi: 10.2217/pgs.09.135. Pharmacogenomics. 2009. PMID: 19891548 No abstract available.

10

Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.

Bieri S, Roosnek E, Ozsahin H, Huguet S, Ansari M, Trombetti A, Helg C, Chapuis B, Miralbell R, Passweg J, Chalandon Y. Bieri S, et al. Among authors: ansari m. Eur J Haematol. 2011 Aug;87(2):138-47. doi: 10.1111/j.1600-0609.2011.01638.x. Eur J Haematol. 2011. PMID: 21535161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,639 results

Search Page

Filters